Catalent Signs Commercial Supply Agreement with Blueprint Medicines...

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today...(PRWeb November 23, 2020)Read the full story at https://www.prweb.com/releases/catalent_signs_commercial_supply_agreement_with_blueprint_medicines_following_fda_approval_of_gavreto_pralsetinib/prweb17562987.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news